{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:21:46Z","timestamp":1762431706175,"version":"3.41.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703666"],"award-info":[{"award-number":["81703666"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01266","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T06:36:12Z","timestamp":1572849372000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacokinetics and Metabolite Profiling of Trepibutone in Rats Using Ultra-High Performance Liquid Chromatography Combined With Hybrid Quadrupole-Orbitrap and Triple Quadrupole Mass Spectrometers"],"prefix":"10.3389","volume":"10","author":[{"given":"Zhi","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingquan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0172026","DOI":"10.1371\/journal.pone.0172026","article-title":"In vivo acrylamide exposure may cause severe toxicity to mouse oocytes through its metabolite glycidamide","volume":"12","author":"Aras","year":"2017","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"127183","DOI":"10.1155\/2017\/1271383","article-title":"New Modified UPLC\/tandem mass spectrometry method for determination of risperidone and its active metabolite 9-Hydroxyrisperidone in plasma: application to dose-dependent pharmacokinetic study in sprague-dawley rats","volume":"2017","author":"Ezzeldin","year":"2017","journal-title":"Int. J. Anal. Chem."},{"key":"B3","unstructured":"Metabolism and disposition of siponimod, a novel selective S1P1\/S1P5 agonist, in healthy volunteers and in vitro identification of human cytochrome P450 enzymes involved in its oxidative metabolism10011013\n            GlaenzelU.\n            JinY.\n            NuferR.\n            LiW.\n            SchroerK.\n            Adam-StitahS.\n          10.1124\/dmd.117.079574Drug Metab. Dispos2018"},{"key":"B4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejps.2018.03.026","article-title":"High resolution mass spectrometry-based methodologies for identification of etravirine bioactivation to reactive metabolites: in vitro and in vivo approaches","volume":"119","author":"Godinho","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/17425255.2018.1519546","article-title":"Drug metabolism and metabolite safety assessment in drug discovery and development","volume":"14","author":"He","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.7150\/thno.15246","article-title":"Pharmacokinetic behaviors of intravenously administered siRNA in glandular Tissues","volume":"6","author":"Huang","year":"2016","journal-title":"Theranostics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1124\/dmd.115.069112","article-title":"Identification of Three novel ring expansion metabolites of KAE609, a new Spiroindolone Agent for the Treatment of Malaria, in Rats, Dogs, and Humans","volume":"44","author":"Huskey","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"B8","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1124\/dmd.115.067850","article-title":"Database extraction of metabolite information of drug candidates: analysis of 27 AstraZeneca compounds with human absorption, distribution","volume":"44","author":"Iegre","year":"2016","journal-title":"Metab. Excretion Data Drug Metab. Dispos."},{"key":"B9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1021\/tx2005212","article-title":"Use of radiolabeled compounds in drug metabolism and pharmacokinetic studies","volume":"25","author":"Isin","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"077002","DOI":"10.1289\/EHP2739","article-title":"Physiologically based pharmacokinetic (PBPK) modeling of the bisphenols BPA, BPS, BPF, and BPAF with new experimental metabolic parameters: comparing the pharmacokinetic behavior of BPA with its substitutes","volume":"126","author":"Karrer","year":"2018","journal-title":"Environ. Health Perspect."},{"key":"B11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bcp.2018.08.043","article-title":"Identification of a novel metabolite of vildagliptin in humans: cysteine targets the nitrile moiety to form a thiazoline ring","volume":"156","author":"Mizuno","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1124\/dmd.114.061416","article-title":"Mass spectrometric evaluation of mephedrone in vivo human metabolism: identification of Phase I and Phase II metabolites, including a novel succinyl conjugate","volume":"43","author":"Ib\u00e1\u00f1ez","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"B13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.talanta.2013.11.014","article-title":"Study on pharmacokinetic and tissue distribution of lycorine in mice plasma and tissues by liquid chromatography-mass spectrometry","volume":"119","author":"Ren","year":"2014","journal-title":"Talanta"},{"key":"B14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jpba.2018.06.050","article-title":"Identification and structural characterization of in vivo metabolites of balofloxacin in rat plasma, urine and feces samples using Q-TOF\/LC\/ESI\/MS\/MS: In silico toxicity studies","volume":"159","author":"Shankar","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s40262-018-0631-z","article-title":"Development of a physiologically based pharmacokinetic model for sinogliatin, a first-in-class glucokinase activator, by integrating allometric scaling, in vitro to in vivo exploration and steady-state concentration-mean residence time methods: mechanistic understanding of its pharmacokinetics","volume":"57","author":"Song","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40262-017-0559-8","article-title":"A Population pharmacokinetic and pharmacodynamic analysis of Abemaciclib in a Phase I clinical trial in cancer patients","volume":"57","author":"Tate","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"B17","unstructured":"2013"},{"key":"B18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.aca.2017.08.047","article-title":"The application of a novel high-resolution mass spectrometry-based analytical strategy to rapid metabolite profiling of a dual drug combination in humans","volume":"993","author":"Xing","year":"2017","journal-title":"Anal. Chim. Acta"},{"key":"B19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.fitote.2014.12.012","article-title":"Pharmacokinetic and tissue distribution profile of curculigoside after oral and intravenously injection administration in rats by liquid chromatography-mass spectrometry","volume":"101","author":"Yuan","year":"2015","journal-title":"Fitoterapia"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01266\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T06:36:17Z","timestamp":1572849377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01266\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":19,"alternative-id":["10.3389\/fphar.2019.01266"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01266","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"article-number":"1266"}}